BioRestorative Therapies, Inc. (BRTX) [Rocket]

In millions, except per share items	Jun-30-23	Sep-30-22	Jun-30-22	Mar-31-22	Sep-30-21	Jun-30-21	Mar-31-21	Sep-30-20
	10-Q	10-Q	10-Q	10-Q	10-Q	10-Q	10-Q	10-Q
Net income								-7.1
Depreciation and amortization								0.2
Stock-based compensation								0.8
Change in working capital [+]								1.4
Accounts receivable								0.0
Other current assets								0.0
Accounts payable								0.6
Accrued expenses								0.7
Other operating activities								1.5
Cash from operations								-3.2

Capital expenditures								0.0
Cash from investing								0.0

Other cash from financing								3.3
Cash from financing								3.3

Free cash flow								-3.2
Per share (diluted)								$0.00